J.P. Morgan Maintains Neutral on MedAssets

J.P. Morgan is out with its report today on MedAssets MDAS, maintaining Neutral. In its report, J.P. Morgan writes, "We maintain our Neutral recommendation given a lackluster outlook for the balance of 2011, but note that with the stock trading at just 11.3x our 2012E EPS, there appears to be good downside protection at current levels." J.P. Morgan maintains an $18 PT on MDAS. Shares of MDAS closed Monday at $12.00, down 5.29% from Friday's close.